View in EDS

B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer.

Saved in:
Bibliographic Details
Title: B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer.
Authors: Kielbik A; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Bahlinger V; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tuebingen, Tuebingen, Germany., Schürch CM; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tuebingen, Tuebingen, Germany., Barcena ML; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Vakhrusheva O; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Thomas A; Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany., Tsaur I; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany., Heitmann JS; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany., Salih HR; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, a Partnership Between DKFZ and University Hospital Tuebingen, Tuebingen, Germany., Hagelstein I; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, a Partnership Between DKFZ and University Hospital Tuebingen, Tuebingen, Germany.
Source: ImmunoTargets and therapy [Immunotargets Ther] 2026 May 01; Vol. 15, pp. 577364. Date of Electronic Publication: 2026 May 01 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101606565 Publication Model: eCollection Cited Medium: Print ISSN: 2253-1556 (Print) Linking ISSN: 22531556 NLM ISO Abbreviation: Immunotargets Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42094867
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kielbik+A%22">Kielbik A</searchLink>; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bahlinger+V%22">Bahlinger V</searchLink>; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schürch+CM%22">Schürch CM</searchLink>; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Barcena+ML%22">Barcena ML</searchLink>; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Vakhrusheva+O%22">Vakhrusheva O</searchLink>; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Thomas+A%22">Thomas A</searchLink>; Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Tsaur+I%22">Tsaur I</searchLink>; Department of Urology, University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Heitmann+JS%22">Heitmann JS</searchLink>; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Salih+HR%22">Salih HR</searchLink>; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, a Partnership Between DKFZ and University Hospital Tuebingen, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Hagelstein+I%22">Hagelstein I</searchLink>; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), Partner Site Tuebingen, a Partnership Between DKFZ and University Hospital Tuebingen, Tuebingen, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101606565%22">ImmunoTargets and therapy</searchLink> [Immunotargets Ther] 2026 May 01; Vol. 15, pp. 577364. <i>Date of Electronic Publication: </i>2026 May 01 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101606565 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2253-1556 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222531556%22">22531556 </searchLink><i>NLM ISO Abbreviation: </i>Immunotargets Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42094867
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/ITT.S577364
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 577364
    Titles:
      – TitleFull: B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kielbik A
      – PersonEntity:
          Name:
            NameFull: Bahlinger V
      – PersonEntity:
          Name:
            NameFull: Schürch CM
      – PersonEntity:
          Name:
            NameFull: Barcena ML
      – PersonEntity:
          Name:
            NameFull: Vakhrusheva O
      – PersonEntity:
          Name:
            NameFull: Thomas A
      – PersonEntity:
          Name:
            NameFull: Tsaur I
      – PersonEntity:
          Name:
            NameFull: Heitmann JS
      – PersonEntity:
          Name:
            NameFull: Salih HR
      – PersonEntity:
          Name:
            NameFull: Hagelstein I
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2253-1556
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: ImmunoTargets and therapy
              Type: main
ResultId 1